1     
OVERDOSE AND SUICIDE FATALITY REVIEW

2     
MODIFICATIONS

3     
2022 GENERAL SESSION

4     
STATE OF UTAH

5     
Chief Sponsor: Raymond P. Ward

6     
Senate Sponsor: ____________

7     

8     LONG TITLE
9     General Description:
10          This bill addresses reviews of an overdose or suicide-related fatality.
11     Highlighted Provisions:
12          This bill:
13          ▸     requires the overdose fatality examiner and psychological autopsy examiner to:
14               •     request discharge information from a health care facility or treatment program if
15     the deceased died within a certain time period after release; and
16               •     develop and distribute a form to be used to obtain the discharge information;
17     and
18          ▸     makes technical and conforming changes.
19     Money Appropriated in this Bill:
20          None
21     Other Special Clauses:
22          None
23     Utah Code Sections Affected:
24     AMENDS:
25          26-4-28.5, as enacted by Laws of Utah 2017, Chapter 346
26          26-4-30, as enacted by Laws of Utah 2020, Chapter 201
27     


28     Be it enacted by the Legislature of the state of Utah:
29          Section 1. Section 26-4-28.5 is amended to read:
30          26-4-28.5. Psychological autopsy examiner.
31          (1) [With] Within funds appropriated by the Legislature for this purpose, the
32     department shall provide compensation, at a standard rate determined by the department, to a
33     psychological autopsy examiner.
34          (2) The psychological autopsy examiner shall:
35          (a) work with the medical examiner to compile data regarding suicide related deaths;
36          (b) as relatives of the deceased are willing, gather information from relatives of the
37     deceased regarding the psychological reasons for the [decedent's] deceased's death;
38          (c) maintain a database of information described in Subsections (2)(a) and (b);
39          (d) in accordance with all applicable privacy laws subject to approval by the
40     department, share the database described in Subsection (2)(c) with the University of Utah
41     Department of Psychiatry or other university-based departments conducting research on
42     suicide;
43          (e) coordinate no less than monthly with the suicide prevention coordinator described
44     in Subsection 62A-15-1101(2); [and]
45          (f) coordinate no less than quarterly with the state suicide prevention coalition[.];
46          (g) if the psychological autopsy examiner determines the deceased was discharged
47     from a health care facility or mental health treatment program within 30 days before the day on
48     which the deceased died, request information from the health care facility or mental health
49     treatment program regarding the deceased's discharge plan; and
50          (h) develop a form to obtain the information described in Subsection (2)(g) that
51     includes:
52          (i) a place for a description of:
53          (A) the deceased's condition upon arrival at the health care facility or mental health
54     treatment program;
55          (B) the reason for the deceased's visit to the health care facility or mental health
56     treatment program;
57          (C) the deceased's length of stay at the health care facility or mental health treatment
58     program; and

59          (D) the deceased's condition upon discharge from the health care facility or mental
60     health treatment program;
61          (ii) an indication of:
62          (A) whether the deceased had a discharge plan upon discharge from the health care
63     facility or mental health treatment program;
64          (B) whether the deceased's discharge plan included mental health treatment; and
65          (C) if the deceased's discharge plan included mental health treatment, whether the
66     health care facility or mental health treatment program took steps to ensure the deceased had
67     access to mental health treatment upon discharge; and
68          (iii) distribute the form described in Subsection (2)(h) to health care facilities and
69     mental health treatment programs in the state.
70          Section 2. Section 26-4-30 is amended to read:
71          26-4-30. Overdose fatality examiner.
72          (1) Within funds appropriated by the Legislature, the department shall provide
73     compensation, at a standard rate determined by the department, to an overdose fatality
74     examiner.
75          (2) The overdose fatality examiner shall:
76          (a) work with the medical examiner to compile data regarding overdose and opioid
77     related deaths, including:
78          (i) toxicology information;
79          (ii) demographics; and
80          (iii) the source of opioids or drugs;
81          (b) as relatives of the deceased are willing, gather information from relatives of the
82     deceased regarding the circumstances of the decedent's death;
83          (c) maintain a database of information described in Subsections (2)(a) and (b);
84          (d) coordinate no less than monthly with the suicide prevention coordinator described
85     in Section 62A-15-1101; [and]
86          (e) coordinate no less than quarterly with the Opioid and Overdose Fatality Review
87     Committee created in Section 26-7-13[.];
88          (f) if the overdose fatality examiner determines the deceased was discharged from a
89     health care facility or substance use treatment program within 30 days before the day on which

90     the deceased died, request information from the health care facility or substance use treatment
91     program regarding the deceased's discharge plan;
92          (g) develop a form to obtain the information described in Subsection (2)(f) that
93     includes:
94          (i) a place for a description of:
95          (A) the deceased's condition upon arrival at the health care facility or substance use
96     treatment program;
97          (B) the reason for the deceased's visit to the health care facility or substance use
98     treatment program;
99          (C) the deceased's length of stay at the health care facility or substance use treatment
100     program; and
101          (D) the deceased's condition upon discharge from the health care facility or substance
102     use treatment program; and
103          (ii) an indication of:
104          (A) whether the deceased had a discharge plan upon discharge from the health care
105     facility or substance use treatment program;
106          (B) whether the deceased's discharge plan included substance use disorder treatment;
107     and
108          (C) if the deceased's discharge plan included substance use disorder treatment, whether
109     the health care facility or substance use treatment program took steps to ensure the deceased
110     had access to substance use disorder treatment upon discharge; and
111          (h) distribute the form described in Subsection (2)(g) to health care facilities and
112     substance use treatment programs in the state.